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Background: Pseudomonas aeruginosa cells are present as bioﬁlms in the paranasal sinuses and the lungs of chronically infected cystic ﬁbrosis
(CF) patients. Since different inﬂammatory responses and selective antibiotic pressures are acting in the sinuses compared with the lungs, we
compared the adaptive proﬁles of mucoid and non-mucoid isolates from the two locations.
Methods: We studied the genetic basis of phenotypic diversiﬁcation and gene expression proﬁles in sequential lung and sinus P. aeruginosa
isolates from four chronically infected CF patients, including pre- and post-lung transplantation isolates.
Results: The same phenotypes caused by similar mutations and similar gene expression proﬁles were found in mucoid and non-mucoid isolates
from the paranasal sinuses and from the lungs before and after transplantation.
Conclusion: Bilateral exchange of P. aeruginosa isolates between the paranasal sinuses and the lungs occurs in chronically infected patients and
extensive sinus surgery before the lung transplantation might prevent infection of the new lung.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.1. Introduction
During the chronic lung infection in patients with cystic
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,lishedperiods under the challenging selective pressure imposed by the
immune system and antibiotic treatment. This is thought to be
due to the biofilm mode of growth [1] and adaptive evolution
mediated by genetic variations [2]. The adapted phenotypes are
characterized by increased alginate production and occurrence of
mucoid variants [3], loss of quorum-sensing (QS) [2,4], motility
[5], effector proteins of the type III secretion system [6] and loss
of the O-antigen components of the lipopolysaccharide [7],
reduced virulence [8], reduced capacity of the non-mucoid
phenotype for in vitro biofilm formation in contrast to the mucoid
which maintain this capacity [9–11] and increased antibiotic
resistance of both phenotypes [12]. These adaptive patterns are
found in P. aeruginosa infecting different CF patients, showing a
parallel evolution of the microorganisms during the chronic
infection [13,14].
There is increasing evidence that the sinuses can be bacterial
foci for P. aeruginosa in CF patients [15]. In the early stages ofby Elsevier B.V. All rights reserved.
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sites of adaptation, where the bacteria get ready to colonize and
infect the lungs. In these stages the migration mainly goes from
the upper to the lower airways [16].
In the later stages of the infection, the paranasal sinuses have
been shown to be a reservoir for bacteria that re-colonize the
lung allograft with the same bacterial clone in patients who have
been lung transplanted [17,18].
The host immune response and the massive antibiotic treat-
ment represent important selective pressures, which influence
the bacterial evolution in the CF airways. It has been shown
that the large number of polymorphonuclear leukocytes (PMNs)
surrounding the biofilms in the lungs could play an important
role in the bacterial evolution in the CF lungs, leading to mucoid
conversion [19] and through oxidative radical damage to
increased mutability [20,21]. However, in addition to impaired
penetration of antibiotics, the infection in the paranasal sinuses
is accompanied by a reduced PMN response due to high local
levels of secretory IgA [22]. These differences in the selective
pressures acting in the paranasal sinuses and the lungs might
influence the bacterial evolution differently in the two locations
[23,16].
Phenotypic characterization, sequencing and gene expres-
sion analyses have previously been used to investigate the evo-
lution and adaptation of P. aeruginosa during infection of CF
airways [14,16,24]. However, a detailed phenotypic character-
ization of the sinus and lung P. aeruginosa isolates from chron-
ically infected patients has not been investigated before. In the
present study, we characterize the adaptive profile of sequential
P. aeruginosa isolates from the upper and lower airways in four
patients with chronic lung infection, three of which have under-
gone lung transplantation (LTX) previous to the sinus surgery.
2. Material and methods
2.1. Patients
Four chronically infected CF women: CF 1, CF 2, CF 3 and
CF 4 (two being homozygous and two heterozygous for the
ΔF508 mutation), three of which underwent LTX before sinus
surgery (CF 1, CF 3 and CF 4) have been included in the study.
The chronic lung infection is defined as growth of P. aeruginosa
in six consecutive monthly sputum samples, or less if there are
two or more precipitating antibodies [25,26].
2.2. Bacteria and culture conditions
The samples from the paranasal sinuses were taken during
Functional Endoscopic Sinus Surgery (FESS) as previously de-
scribed [23]. Sputum samples were obtained by expectoration
and investigated as previously described including Gram-staining
and microscopy to confirm the origin from the lower airways by
identification of cylinder epithelial cells and inflammatory cells
and absence of squamous epithelial cells [27]. P. aeruginosawas
the only bacterial pathogen cultured from the samples. Mucoid
and non-mucoid isolates were considered paired when simulta-
neously present in a sample.Fifty-two sequential paired mucoid and non-mucoid
P. aeruginosa isolates from the lungs and paranasal sinuses
of the four CF patients were included in this study. Fifteen
of them represented mucoid and non-mucoid pairs from the
paranasal sinuses. Four pairs of mucoid and non-mucoid
isolates from sputum samples (eight isolates in total) collected
close to the time of sinus surgery were chosen for comparison
to the sinus samples (a total of twenty-three isolates represent
sino-pulmonary samples).
The remaining samples represented sequential lung isolates
collected before and after sinus surgery from the bacterial
collection available at the Department of Clinical Microbiolog-
ical, Rigshospitalet. A complete list of all isolates is presented in
Supplementary Table 1. Prior to phenotypic analyses (see later),
all isolates were grown in LB media, at 37 °C.
2.3. P. aeruginosa genotyping
The relatedness of the isolated strains and identification of
genotypes were assessed by Pulsed-field gel electrophoresis
(PFGE). For the PFGE analysis, bacterial DNA was digested
with the restriction enzyme Spe I (BioLabs, Inc., New England)
and PFGE was carried out by contour-clamped homogeneous
electric field electrophoresis (CHEF-DR III apparatus, Bio-Rad,
Munich). Evaluation of similarity was done according to Tenover
et al. [28].
2.4. Determination of protease activity
Supernatant from an overnight culture (50 μl) was applied to
skim milk plates followed by overnight incubation at 37 °C.
The diameter of the clearing zone surrounding the inoculation
spot was measured indicating the ability of isolates to produce
proteases.
2.5. Motility assays
2.5.1. Swimming
Cells from one colony were inoculated by use of a sterile
toothpick on tryptone plates containing 1% tryptone, 0.5%NaCl
and 0.3% Bacto agar. The swimming zone was measured after
24 h incubation at 25 °C.
2.5.2. Swarming
Swarm plates were composed of 0.5% Bacto agar and 8 g
nutrient broth/L and 5 g dextrose/L. The plates were dried for 2 h
at room temperature. Cells from one colony were inoculated on
the surface of the plates. The plates were incubated at 30 °C for
24 h, and the surface locomotion of the bacteria was observed.
2.6. Determination of antibiotic susceptibility
The minimal inhibitory concentration (MIC) was determined
on 105 CFU/ml of P. aeruginosa by using the E-test system
(Biomérieux, Marcy-l'Etoile, France) according to instructions
of the manufacturer.
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P. aeruginosa isolates
The mutation frequencies were investigated on rifampicin
(300 mg/L) and streptomycin (500 mg/L) containing LB plates
as previously described [20]. An isolate was considered hyper-
mutable when the mutation frequency was 20 fold higher than
the mutation frequency of the reference strain PAO1 (≥3×E-7).2.8. Sequence of mucA, algT, lasR, rpoN, mutS and mutL and
PCR for deletions in region PA1428-PA1431 (lasR) and
PA4120-PA4122 (hpc operon)
To investigate the genetic background of alginate produc-
tion, changes in QS regulation and hypermutability, the
alginate regulatory genes mucA and algT, the gene encoding
the QS-regulator LasR and genes involved in DNA repair
mutS and mutL have been sequenced using previously published
primer sets [14]. In one of the dominant clones present among
patients attending the Copenhagen CF Center (called DK_2
[27]), changes in the aminoacid sequence of RpoN as well as
deletions in PA1428-1431 and PA 4120-PA4122 genes have
previously been detected [13]. PA1428-1431 includes the lasR
gene (PA1430) and PA 4120-PA4122 contains the transcrip-
tional regulator of hpc operon encoding genes involved in
the catabolism of 4-hydroxyphenylacetic acid (4-HPC) [13].
Therefore, in isolates belonging to DK_2 clone from CF 3 and
CF 4, the rpoN gene has been sequenced using previously
published primer sets and the deletions in PA4120-PA4122
and PA1428-1431were investigated by PCR as previously
described [13]. The sequencing results were compared to
strain PAO1 sequence (http://www.pseudomonas.com/) with
DNASIS Max version 2.0 (Hitachi software Engineering), in
order to determine sequence variations.2.9. Gene expression analysis
The gene expression profile was investigated in mucoid and
non-mucoid isolates representing sino-pulmonary samples. The
isolates included are shown in Supplementary Tables 1 and 4.
The strains were cultured in LB to an OD600=1.0. Four ml of
each culture was harvested and RNA isolation and purification
were performed using RNA Protect Bacteria Reagent and
RNeasy Mini Kit (Qiagen, Germany). RQ1 RNAse free DNAse
(Promega) was added to remove contaminating DNA. The
experiment was run in triplicates.
Processing of the P. aeruginosa GeneChip (Affymetrix) was
performed at the Department of Clinical Biochemistry,Microarray
Core Unit, Rigshospitalet, University of Copenhagen, Denmark.
The gene expression analysis was done by ArrayStar v.5
Software (DNASTAR). The data sets were normalized using
Robust Multiarray Analysis method. The data were clustered by
the hierarchical method. Differences in gene expression between
isolates from upper and lower airways were tested using
Student's t-test with FDR (Benjamini–Hochberg) correction for
multiple testing. Genes were considered differently expressed ifthe fold-change was higher than 2-fold with confidence of
pb0.05.
2.10. Statistical analysis
The description and analysis of the phenotypic data were
carried out using StatViewH 5.0.1. software. The data are given
as means±SDs. The unpaired t test was used for comparison of
the data for mucoid and non-mucoid isolates from sinus and
lung of the sino-pulmonary samples.
3. Results
3.1. Clonal distribution
Isolates collected from the sinuses and lungs from patient CF
1 belonged to DK_1 clone, from patient CF 3 and CF 4 to DK_2
clone and from patient CF 2 to a unique clone. DK_1 and DK_2
clones are two of the dominant clones among the 21 different
P. aeruginosa clones that have been identified among chroni-
cally infected CF patients at Copenhagen CF Centre [27,29,30].
3.2. Phenotypes
All isolates, from the paranasal sinuses and lower airways
showed adapted phenotypes with lack of protease activity and
decreased motility compared with the wild-type P. aeruginosa
(Supplementary Table 2). In three patients (CF 1, CF 2 and CF 3)
mutator isolates were identified in non-mucoid or mucoid or both
morphotypes as shown by the mutations identified in mut genes
(Table 1). In the case of CF 1 and CF 3, the hypermutable isolates
were identified in the CF lungs before transplantation, as well as
in the allograft, and in the paranasal sinuses (Supplementary
Table 1).
Due to possible differences in the selective pressures in the
upper and lower parts of the united airways, we would have
expected differences in the phenotypes of the mucoid and non-
mucoid isolates from paranasal sinuses and lungs. However, no
statistically significant difference between swimming, swarm-
ing motility and mutation frequencies was observed between
mucoid or non-mucoid isolates from the sino-pulmonary sam-
ples (Supplementary Table 2). A tendency towards higher MIC
values of all antibiotics in lung isolates compared to sinus
isolates has been observed, though the differences did not reach
the statistical significance with the exception of ceftazidime;
MIC values (mean±SD) in non-mucoid sinus and lung isolates
were 5.2±5 and 128.4±147.3 μg/ml, respectively, p=0.03
(Supplementary Table 3).
3.3. Genetic basis of adaptation
Sequence analysis ofmucA, algT and lasR identified the types
of mutations present in mucoid and non-mucoid P. aeruginosa
isolates (Table 1). These genotypes were found in the two
morphotypes from sinus and lung and the same mutations were
identified in lung isolates obtained prior to FESS and after
T
ab
le
1
T
he
ty
pe
of
no
n-
sy
no
ny
m
ou
s
m
ut
at
io
ns
in
m
uc
A
,a
lg
T
,l
as
R
,m
ut
S
or
m
ut
L
an
d
th
e
pr
es
en
ce
of
Δ
P
A
14
28
-3
1
an
d
Δ
P
A
41
20
-2
2
in
th
e
D
K
_2
cl
on
e
(s
ee
M
at
er
ia
la
nd
m
et
ho
ds
)
in
P
.a
er
ug
in
os
a
is
ol
at
es
fr
om
lu
ng
an
d
pa
ra
na
sa
l
si
nu
se
s
in
ea
ch
of
th
e
fo
ur
pa
tie
nt
s.
T
he
m
ut
at
io
ns
ar
e
pr
es
en
te
d
as
th
e
ty
pe
of
ba
se
ch
an
ge
an
d
th
e
po
si
tio
n
re
pr
es
en
ts
th
e
ba
se
nu
m
be
r
fr
om
th
e
ge
ne
st
ar
t.
N
C
=
no
ch
an
ge
m
ea
ns
no
am
in
oa
ci
d
ch
an
ge
co
m
pa
re
d
to
th
e
se
qu
en
ce
of
th
e
re
fe
re
nc
e
st
ra
in
P
A
O
1.
A
fu
ll
lis
t
of
th
e
id
en
tif
ie
d
m
ut
at
io
ns
in
al
l
th
e
is
ol
at
es
is
pr
es
en
te
d
in
S
up
pl
em
en
ta
ry
T
ab
le
1.
C
om
bi
na
tio
n
of
m
ut
at
io
ns
C
F
1
(D
K
_1
)
C
F
2
C
F
3
(D
K
_2
)
C
F
4
(D
K
_2
)
M
or
ph
ot
yp
e
N
M
M
N
M
M
N
M
M
N
M
M
m
uc
A
N
C
C
34
9T
Δ
10
5
bp
@
30
6
or
N
C
C
35
2T
Δ
G
43
0
Δ
G
43
0
In
sG
G
at
14
2
Δ
G
43
0
or
Δ
G
43
0
In
sG
G
at
14
2
Δ
G
43
0
or
Δ
G
43
0
al
gT
C
49
9T
N
C
or
G
92
A
N
C
N
C
A
55
G
A
55
G
A
55
G
A
55
G
la
sR
C
53
8T
N
C
C
29
2T
C
29
2T
(Δ
P
A
14
28
-3
1)
(Δ
P
A
14
28
-3
1)
(Δ
P
A
14
28
-3
1)
(Δ
P
A
14
28
-3
1)
m
ut
ge
ne
s
m
ut
L
:
A
18
35
G
m
ut
S:
Δ
A
24
29
N
hp
m
ut
S
Δ
15
bp
@
10
98
m
ut
L:
in
se
rt
io
n
C
G
C
G
G
G
C
at
12
81
N
C
or
m
ut
L:
in
se
rt
io
n
C
G
C
G
G
G
C
at
12
81
N
C
N
C
rp
oN
T
12
56
C
T
12
56
C
T
12
56
C
T
12
56
C
Δ
P
A
41
20
-2
2
N
C
or
Δ
P
A
41
20
-2
2
N
C
N
C
N
C
732 O. Ciofu et al. / Journal of Cystic Fibrosis 12 (2013) 729–736sinus surgery in the CF lung and in the allograft (Supplemen-
tary Table 1).
For isolates belonging to the DK_2 clone, single nucleotide
polymorphism (SNP) of the rpoN and PA4120-22 deletion in
the hpc operon were also investigated as these have previously
been identified to characterize this clone (Table 1). All isolates
belonging to DK_2 had the same SNP in rpoN representing
a single nucleotide substitution T1256C causing aminoacid
change from L419 to P, located in the DNA binding domain
which is proximal to DNA in the promoter/holoenzyme com-
plex (Table 1). This was to be expected as this mutation has
been shown to occur early during the adaptation of the DK_2
clone. The rpoN mutation was found in DK_2 isolates back in
1979, before the cohorting of the CF patients in the Copenhagen
CF Center which started in 1981 and stopped the spread of the
two dominant clones [13,31].
The deletion PA4120-22 which encodes the transcriptional
regulator of the hpc operon that is responsible for degradation of
4-hydroxyphenylacetic acid (4-HPC) was identified in the non-
mucoid isolates of CF 3 but not in the mucoid isolates (Table 1).
The adaptive patterns of P. aeruginosa isolated from the right
and left sinuses (CF 3, CF 4) were identical to those of the lung
isolates (Supplementary Table 1). This was in contrast to the
different adaptive patterns reported in P. aeruginosa isolated
from the left and right sinuses in an intermittently colonized
patient [16].
The same genetic bases for hypermutability were identified in
isolates from lungs and sinuses of CF 1, CF 2 and CF 3, respec-
tively (Supplementary Table 1).
The types of mutations in the mucoid isolates were different
from the mutations in the non-mucoid isolates (Table 1). For
example, in CF 1 the mucoid isolates had C349TmucAmutation
and ΔA2429 mutation in mutS while the non-mucoid isolates
had nomucAmutation, C538T in lasR leading to premature stop
codon [32] and A1835G in mutL. This combination of muta-
tions was maintained for at least ten years through the infection
course in the patients' lower airways (Supplementary Table 1).
The same combination of mutations was identified in isolates
from the transplanted lung as well as in isolates from the para-
nasal sinuses of CF 1 (Supplementary Table 1).
In CF 2, another combination of mutations, C352T mucA
mutation, C292T mutation in lasR and Δ15bp@1098 in mutS,
characterized the mucoid isolates while the non-mucoid isolates
hadΔ105bp@306 inmucA, C292Tmutation in lasR andwere not
hypermutable. These combinations of mutations were found in
isolates from the lung and sinuses before and after FESS. In this
patient, at least two different subpopulations of the non-mucoid
isolates were found, some with Δ105bp@306 in mucA (isolate
from 1992 to 2007) and a subpopulation with wild-type mucA.
These data are in correspondence to previous reports on the
adaptation of the mucoid and non-mucoid phenotype to the
different niches in the CF lung [10,33,34].
3.4. Gene expression profiles
Hierarchical clustering of the gene expression data of the
sino-pulmonary samples taking into account all 5886 genes on
733O. Ciofu et al. / Journal of Cystic Fibrosis 12 (2013) 729–736Affimetrix chip showed that the mucoid isolates from the lungs
and sinuses clustered together and separate from the non-
mucoid isolates (Fig. 1). Interestingly, the mucoid isolates of CF
3 and CF 4, which belong to clone DK_2, were clustered
together, confirming the parallel evolution of this clone in two
different patients. When gene expression of all sinus samples
was compared to gene expression data of all the lung samples no
genes with statistically significant differential expression were
found between isolates from sinuses and lungs (Supplementary
Fig. 1). The number of genes differentially expressed at 2 fold
and 95% confidence interval between the mucoid and non-
mucoid isolates in the paranasal sinuses were 152 and 147 in the
lungs, respectively showing the different phenotypes expressed
by these two morphotypes in the airways (Supplementary Fig. 2)P.
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Fig. 1. Dendogram (Heat Map) of the hierarchical clustering of the gene expressio
isolates. The dendogram uses color to display the expression levels of many genes ac
column represents one isolate. The dendogram shows that the mucoid isolates from f
unique clone) are clustering together and therefore have similar gene expression profi
separate from the mucoid isolates. No non-mucoid isolates were available from th
phenotype and therefore these are not represented in the figure.confirming previous studies showing that the two phenotypes
follow different evolutionary pathways due to adaptation to dif-
ferent niches in the lungs [10,33,34].
Comparisons of the sinus and lung isolates within individual
patients showed a variable number of differentially expressed
genes. Interestingly, up-regulation in the sinus isolates of nar
genes involved in nitrogen metabolism and anaerobic respiration
was observed in CF 3 and up-regulation of the genes involved in
arginine metabolism was observed in CF 2. Up-regulation in the
sinus isolates of genes involved in type VI secretion and pyochelin
biosynthesis was observed in CF 1 (Table 2). Thus, it looks like
adaptation to the paranasal sinuses does not occur through
common pathways but through various pathways as identified
in the four CF patients. isolates
n of all 5886 genes in P. aeruginosa mucoid and non-mucoid sinus and lung
ross the different isolates. Each row corresponds to one specific gene, and each
our different CF patients belonging to three different clones (DK_1, DK_2 and a
les in the sinuses and lungs. The non-mucoid isolates are clustering together and
e lung for CF 4 and the lung mucoid isolate of CF 3 reverted to non-mucoid
Table 2
Selected genes with significant differential expression in isolates from lung and sinus of CF 1, CF 2 and CF 3. The fold change in the gene expression of the isolates
from the sinuses is presented in comparison to the gene expression of the lung isolates.
Patient PA Gene symbol Pathway Fold change p value
CF 1
2007M_40951C
(control) vs 2007M_right
sinus maxillaris 90B
(experiment)
PA0083_at tssB1 Type VI secretion system 32 up 0.0472
PA0084_at tssC1 Type VI secretion system 23.3 up 0.0496
PA0085_at hcp Type VI secretion system 54.8 up 0.0447
PA0095_at VgrG1b Type VI secretion system 3.4 up 0.0364
PA4226_pchE_at pchE Pyochelin synthesis 14.3 up 0.0482
PA4228_pchD_at pchD Pyochelin synthesis 10.2 up 0.0407
CF 2
2007M_2626A
(control) vs. 2007M_ left
maxillaris_71A
(experiment)
PA5172_arcB_at arcB Arginine and proline metabolism,
urea cycle and metabolism of amino groups
11.8 up 0.0444
PA5173_arcC_at arcC Arginine and proline metabolism,
glutamate metabolism, nitrogen metabolism
11.3 up 0.0375
CF 3
2009NM_39295B
(control) vs. 2008NM_306B,
307B, 308B
(pooled triplicates from three
NM sinus isolates- experiment)
PA3870_moaA1_at moaA1 Molybdopterin biosynthesis 9.5 up 0.01
PA3871_at 30.5 up 0.005
PA3872_narI_at narI Nitrogen metabolism 29.3 up 0.003
PA3873_narJ_at narJ Nitrogen metabolism 38.9 up 0.002
PA3874_narH_at narH Nitrogen metabolism 18.1 up 0.0175
734 O. Ciofu et al. / Journal of Cystic Fibrosis 12 (2013) 729–736A full list of genes with significantly different expression in
mucoid and non-mucoid isolates from the sinus compared to
the lung is presented in Supplementary Table 4.
4. Discussion
It has previously been shown that P. aeruginosa form bio-
films in the sinuses in chronically infected patients similar to the
biofilms in the lungs but with an important difference in the
inflammatory response; there were only very few PMNs around
the biofilms in the sinuses in contrast to the significant amount
of PMNs surrounding the biofilms in the lungs [23]. This was
attributed to the non-inflammatory secretory IgA response,
which may prevent local and systemic inflammation and recog-
nition of microorganisms [22,23]. The different inflammatory
conditions that characterize the upper and lower parts of the
united airway probably cause different selective pressures for
the evolutionary process of the bacteria residing in the two
locations. This might be reflected in different evolutionary
pathways followed by the bacteria in the sinuses and lungs [16].
However, we found that the genetic basis of adaptation and the
subsequent gene expression phenotypes were similar in sinus
and lung isolates from chronically infected patients. This could
be interpreted as either I. the entire adaptive process occurs in
the sinuses and subsequently adapted isolates infect the lung or
II. that in spite of the differences in the inflammatory response
identified in the two niches of the united airways, the bacteria
follow similar adaptive pathways in the paranasal sinuses and in
the lung or III. that lung-adapted isolates might move upwards
into the nasopharynx and reach the sinuses during cough,
physiotherapy or when using the peep-mask. That bacteria from
the naso-pharynx flora can reach the paranasal sinuses is known
from the etiology of bacterial acute sinusitis which involves
microorganisms present in the nasopharynx such as Streptococcus
pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
[35]. Acute sinusitis often occurs after viral infections of the
upper respiratory tract. During a viral respiratory infection causingrhinosinusitis, viscous fluid accumulates in the nose. Nose blowing
generates high intranasal pressures that can propel the nasal fluid
secretions into the paranasal sinuses [36,37].
From the dynamic of occurrence of the various phenotypes
during the chronic lung infection, we learnt that the hypermutable
phenotype, which correlates to antibiotic resistance, occurred late
during the chronic lung infection [14] and was associated to
oxidative DNA lesions caused by the PMN inflammatory
response [20]. In spite of the few PMNs and the weaker selection
by antibiotics that characterize the paranasal sinuses [23], isolates
with hypermutable phenotype were isolated from sinuses. These
isolates had identical mutations in mutS and mutL as the lung
isolates suggesting their occurrence in the lung with later migra-
tion to the sinuses. The similar adaptive profile of the mucoid and
non-mucoid isolates encountered in the right and left parts of the
paranasal sinuses (CF 3, CF 4) is in favor for a movement of
bacteria from the lungs to the sinuses. It has been shown that in
the early intermittently colonization stage, the bacteria evolve
different in the right and the left side of the paranasal sinuses [16]
and move from the sinuses to the lungs.
The similar combination of mutations in several genes iden-
tified in the isolates from the sinuses and lungs make the
possibility of independent bacterial evolution in the sinuses and
lung (II.) rather improbable as the chance of acquiring the same
mutations in several genes is improbable but not impossible.
Systematic prospective studies of sinus and lung isolates in CF
patients before and after chronic colonization could be suitable
to elucidate this question.
The specific combination of mutations in the investigated
genes characterizing the mucoid or non-mucoid isolates was
maintained for long period in the lungs and sinuses (Table 1 and
Supplementary Table 1). This dynamic supports the different
evolutionary pathways followed by the two morphotypes [10].
It has been proposed that the mucoid isolates are adapted to the
aerobic niches, where they are protected from the mutagenic
effect of reactive oxygen species by alginate, while the non-
mucoid isolates are adapted to the anaerobic niches [33,34].
735O. Ciofu et al. / Journal of Cystic Fibrosis 12 (2013) 729–736It has been shown that anaerobe niches are present in the
sinuses [38], similar to the anaerobic conditions met in the
sputum [39] from where both mucoid and non-mucoid isolates
are frequently isolated.
After reaching the sinuses during episodes of upper respiratory
viral infections, the lung-adapted isolates will probably reside in
the paranasal sinuses from where they can migrate downwards to
the lung, through drainage and aspiration [16,23].
While residing in the upper part of the united airways, the
microorganisms might elicit adaptive responses to the specific
selective pressures encountered in the sinuses.
For example, the higher susceptibility to ceftazidime of the
sinus isolates compared with the lung isolates can be explained
by the fluctuations in the bacterial subpopulations that occur
during antibiotic treatment [40] suggesting a lower selective
pressure exerted by beta-lactam antibiotics in the sinuses com-
pared with the lungs. From our analysis of the gene expression
results, we could not identify a common pathway of adaptation
to the paranasal sinuses in these isolates from the chronically
infected patients. However, the up-regulation in the sinus
isolates of operons involved in anaerobic respiration or arginine
fermentation in CF 3 and CF 2 might be interpreted as adaptive
responses of P. aeruginosa to the anaerobic environment de-
scribed in the sinuses [38]. The down-regulation in isolates of
CF 1 of the type VI secretion system and pyochelin genes in the
lung compared with the sinus isolates might reflect the dif-
ference in the inflammatory response between the two locations
of the united airways [22,23]. It has been shown that the sidero-
phore pyochelin is down regulated in the presence of hydrogen
peroxide [41] probably as a protective mechanism against
reactive oxygen species produced by Fenton reaction, which
involves iron. Down-regulation of type VI secretion system in
the lung would lead to decrease virulence factor productions and
subsequent lack of PMN recruitment to the site of infection.
In the three patients, who had undergone lung transplanta-
tion, the isolates that infected the allograft had similar adaptive
patterns as isolates collected before the transplant from the CF
infected lungs as well as the isolates from the paranasal sinuses
of the patients. This suggests that the transplanted lungs have
become infected with already adapted P. aeruginosa isolate that
probably hide mainly in the sinuses. Therefore, extensive sinus
surgery and postoperative treatment before or in relation to LTX
might have preventive effects on the post-transplant infection.
This was shown by Holzmann et al. [42] who did extensive
surgery and thorough follow-up, finding a lower incidence of
tracheobronchitis and pneumonia after LTX and that eradi-
cation of the sinus bacteria was possible. Recently, Vital et al.
[43] showed that sinus surgery and daily nasal douching reduced
P. aeruginosa in lung transplant recipients and absence of
post-transplant colonization with P. aeruginosa had a positive
impact on post-transplant survival and development of bronchi-
olitis obliterans. Conflicting results showing no effect of sinus
surgery on the recolonization of the lung allograft in CF patients
have been published [44,45]. However, in these retrospective
studies there was a lack of post-surgical treatment of the sinuses
and the sinus surgery was not as extensive as in the studies
reporting positive results.We are convinced that the sinuses can be a reservoir for CF
pathogens and that these bacteria can drain/migrate/be aspirated
to the lower airways in LTX CF patients [16,46]; it is more
debatable what can be done to prevent it. Vital et al. [43] suggests
sinus surgery after recovery from LTX (mean days after LTX 36)
combined with nasal irrigations and IV and nebulized antibiotic
therapy. Mainz et al. [47] found an effect of ongoing Colomycin
1 MIU with a Pari Sinus™ nebulizer.
In conclusion, in chronically infected CF patients the
P. aeruginosa isolates from sinuses and lungs show the same
phenotype caused by similar mutations in global gene regulators
suggesting a bidirectional movement between the two compart-
ments of the united airways.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.jcf.2013.02.004.
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